WHO issues global warning on fake GLP-1 RAs

WHO Global Surveillance and Monitoring System observes increasing reports of “falsified semaglutide products in all geographic regions”  The World Health Organization (WHO) has issued a medical product alert related to three batches of Ozempic discovered in Brazil, the UK and the US late last year.   In a statement issued yesterday (Thursday 20 July 2024)

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘If he were caught in an open shop he would be guilty’
Next Pharmacy leaders rough it for Vinnies